Independent analysis
DSIP
- Purity
- 98.887%
- Tested quantity
- 16.62 mg
- Report date
- March 25, 2026
- Task ID
- #123268
FREE CANADA-WIDE EXPRESS SHIPPING ON ORDERS OVER $350
Reviews transferred over to Yotpo (over 140 reviews)
🍁 Owned and operated by a CF Veteran 🇨🇦
FREE Pfizer BW on Purchases over $500: blackdragon, 10% off: peptide party
SALE IN EFFECT, NEUROTROPIN GH 100iu $250 (while quantities last)
Pfizer bac water – In stock New Batch of G-H coming. RESTOCKED – Please double-check junk mail for emails
$120.00 Original price was: $120.00.$89.99Current price is: $89.99.
In stock
Research use only; Not for human or veterinary administration. This content is not a substitute for medical advice.
DSIP (delta sleep-inducing peptide) is a naturally occurring nonapeptide studied in sleep and neuroendocrine research models. This Canadian product listing concerns laboratory research material only. It is not an authorized medicine, does not provide dosing or administration instructions, and is not intended for human or veterinary use.
DSIP Canada researchers can order DSIP 15mg directly from Red Leaf Research Labs. This listing supplies a single 15mg vial of lyophilized delta sleep-inducing peptide for qualified laboratory use, with published analytical information, Canadian-dollar pricing and domestic express fulfilment.
For searches such as buy DSIP Canada, DSIP 15mg or delta sleep-inducing peptide Canada, the practical questions are the same ones that apply to any research peptide: what is in the vial, who tested it, when it was tested, and whether the buyer is authorized to obtain research-use material.
Red Leaf Research Labs supplies research material to qualified purchasers in Canada. Nothing on this page describes a therapy, a treatment or a permitted personal use.
| Attribute | Detail |
|---|---|
| Research format | DSIP 15mg, single vial |
| Physical state | Lyophilized powder |
| Analytical documentation | Third-party report available for the current lot |
| Fulfilment | Domestic Canadian express shipping |
| Intended use | Qualified laboratory research only |
DSIP is a nine-amino-acid peptide first isolated in the 1970s from the cerebral venous blood of rabbits in which slow-wave sleep had been induced. The name comes from that isolation context rather than from an established mechanism, and the distinction matters.
Unlike most compounds on a research catalogue, DSIP has no confirmed receptor. Decades of published work have implicated interactions with neurotransmitter and opioid-related pathways, but no single receptor or complete mechanism accounts for the effects reported in the original isolation experiments. Some later work has questioned how reproducible those original findings are.
That is an unusually honest thing for a product listing to say, and it is said here because a laboratory designing work with DSIP needs to know it going in. The compound is a legitimate research subject; it is not a well-characterised tool with a settled mechanism.
The published record on DSIP spans sleep architecture, stress-response endpoints, neuroendocrine signalling and analgesia-related models, and it is scattered across several decades and research traditions. Replication is patchy, and the peptide’s short half-life in circulation complicates interpretation of whole-organism work.
What this means practically: findings should be read as protocol-specific rather than as properties of the molecule. A result observed in one model does not establish a safety profile, an effect size, or an appropriate use in any person, and the absence of a confirmed receptor means there is no mechanistic account to extrapolate from.
DSIP is a short peptide with a straightforward stability profile in lyophilized form, so domestic supply buys turnaround and traceability more than it buys preservation.
That said, for a compound whose published record is as uneven as DSIP’s, controlling the variables you can control matters disproportionately. Knowing the material’s provenance and having a Canadian counterparty to query about a lot is one of the few sources of certainty available on this compound.
DSIP is a short, well-defined nonapeptide, which makes identity testing straightforward — and makes a vague report harder to excuse.
Red Leaf publishes Janoshik reports with a verification key. For a compound whose literature is as thin as DSIP’s, knowing exactly what is in the vial is the one variable you can actually control.
The 15mg vial arrives as a lyophilized cake. Lyophilization is a drying step; it neither purifies the material nor certifies it.
DSIP’s short sequence and acidic residues make solution pH worth attending to during preparation, and its brief circulating half-life means whole-organism designs have to account for delivery in a way that in-vitro work does not. Inspect the cake, connect the vial to its report, and follow validated institutional procedures. Background on diluent choice is in bacteriostatic water uses and handling.
Fulfilment is to qualified Canadian purchasers by domestic express. Red Leaf supplies material and documentation; it does not advise on study design and provides nothing that supports use in humans or animals.
DSIP holds no marketing authorization in Canada. It has not been assessed for consumer safety or effectiveness by Health Canada, and given the state of the mechanistic literature, that absence should not be read as an oversight.
Research supply and public medical availability are separate categories. A vial available to a qualified laboratory is not an approved retail medicine, a sleep aid, or a substitute for professional care. Anyone searching from a personal sleep concern should speak with a licensed clinician rather than a research supplier.
| Check | What to confirm |
|---|---|
| Purpose | Authorized laboratory research with an approved study plan |
| Identity | DSIP name, CAS 62568-57-4 and the WAGGDASGE sequence |
| Quantity | DSIP 15mg research format |
| Documentation | Current lot reference, test date, measured amount and purity result |
| Verification | Report can be checked against the issuing laboratory |
| Study design | Endpoints chosen with the absence of a confirmed receptor in mind |
| Handling | Storage and preparation procedures validated by the receiving institution |
For supplier-selection criteria in the Canadian market, review how to evaluate a Canadian research peptide supplier. For a wider survey of compounds studied in this space, see research peptides worth knowing.
No. Published work has implicated neurotransmitter and opioid-related pathways, but no single confirmed receptor or complete mechanism accounts for the reported effects.
From the 1970s isolation experiments, in which the peptide was recovered from the cerebral venous blood of rabbits in induced slow-wave sleep. It describes an isolation context, not a demonstrated mechanism.
Patchily. The record is scattered across several decades and research traditions, and the peptide’s short circulating half-life complicates interpretation of whole-organism work.
No. It holds no Canadian marketing authorization and has not been assessed for consumer safety or effectiveness.
No. Red Leaf Research Labs supplies research material and analytical documentation only.
Research use only. DSIP supplied by Red Leaf Research Labs is intended for qualified laboratory research. It is not a medicine, not for human or veterinary use, and not for diagnostic or therapeutic application.
Independent third-party testing
Review available analytical reports associated with this product.
Independent analysis
A certificate describes the submitted sample shown in that report. It does not establish clinical safety, efficacy, or suitability for human or veterinary use.
Third-party tested purity
Ultra high synthesis purity
Temperature controlled logistics
Trusted by researchers worldwide
This product is supplied in a lyophilized powder form to preserve its stability, purity, and potency.
For laboratory research purposes only. Not intended for human consumption.

You must be 18 or 19 years of age depending on the age of majority in your province and a licensed research professional
All products are sold in powder (lyophilized) form and require reconstitution with a suitable diluent for research purposes only. No dosing instructions are provided. We adhere to all provincial and federal laws in Canada around Research Only Chemical sales. We are not a pharmacy and/or compounding facility, nor do we promote or provide any advice for human or animal consumption.
By clicking ”I Agree” you confirm that you have read and accepted the Terms and Conditions stated above